Giuliano M, Pantosti A, Gentile G, Venditti M, Arcese W, Martino P
Laboratorio di Batteriologia e Micologia Medica, Università La Sapienza, Rome, Italy.
Antimicrob Agents Chemother. 1989 Oct;33(10):1709-13. doi: 10.1128/AAC.33.10.1709.
We monitored the modifications of oral and intestinal microfloras of 10 allogeneic bone marrow recipients who received randomly either norfloxacin or pefloxacin (400 mg three times a day) as selective decontamination for infection prevention. After 1 week of treatment, in all patients members of the family Enterobacteriaceae were no longer detectable and in all but one pefloxacin-treated patient enterococci were also eliminated in the intestine. The anaerobic flora was not affected, with the exception of Bacteroides spp., markedly reduced after treatment with pefloxacin. In most patients the most striking effect was the increase in staphylococcal counts. These strains were found to be resistant to both quinolones in the study. Less consistent changes were observed in oral flora. No relevant difference could be demonstrated between the two regimens on bacterial counts either in feces or in saliva. This study shows the efficacy of both quinolones in eradicating gram-negative bacilli in the alimentary tract of bone marrow transplant patients; however, the finding of the overgrowth of resistant gram-positive organisms during treatment with these agents deserves further evaluation.
我们监测了10名异基因骨髓移植受者的口腔和肠道微生物群的变化,这些患者被随机给予诺氟沙星或培氟沙星(每日三次,每次400毫克)作为预防感染的选择性去污剂。治疗1周后,所有患者的肠杆菌科成员均不再可检测到,除1名接受培氟沙星治疗的患者外,所有患者肠道中的肠球菌也被清除。厌氧菌群落未受影响,但在用培氟沙星治疗后,拟杆菌属显著减少。在大多数患者中,最显著的影响是葡萄球菌计数增加。在该研究中发现这些菌株对两种喹诺酮类药物均耐药。口腔微生物群的变化不太一致。在粪便或唾液中的细菌计数方面,两种治疗方案之间未显示出相关差异。本研究表明两种喹诺酮类药物在根除骨髓移植患者消化道中的革兰氏阴性杆菌方面均有效;然而,在用这些药物治疗期间耐药革兰氏阳性菌过度生长的发现值得进一步评估。